Regeneron Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Okay. Good morning, ladies and gentlemen, and welcome. Welcome also to those attending the meeting via our webcast. It's 10:30 and time to call the Annual Meeting of Shareholders of Regeneron Pharmaceuticals to order. I am Roy Vagelos, Chairman of the Board.
On my left is Len Schleifer, President and Chief Executive Officer and a member of the Board of Directors of Regenferon. On Dr. Schleifer's left is Joe LaRosa, Executive Vice President, General Counsel and Corporate Secretary and secretary of this meeting.
Also present this morning are other senior officers of Regeneron. I'll ask them to stand when I introduce them. George Yancopoulos, Founding Scientist, President and Chief Scientific Officer. George is also a member of the company's Board of Directors.
Bob Landry, Executive Vice President, Finance and Financial -- Chief Financial Officer; Drew Murphy, Executive Vice President of Research; Hanne Bak, Senior Vice President, Preclinical Manufacturing and Process Development; Aris Baras, Senior
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
